XML 75 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information (Tables)
 9 Months Ended
Sep. 26, 2020
Segment Reporting [Abstract]  
Schedule of Segment Reportable Segments, by Segment
The following tables set forth certain information relating to our segments’ operations:
(amounts in thousands)North
America 		EuropeAustralasiaTotal Operating
Segments		Corporate
and
Unallocated
Costs		Total
Consolidated
Three Months Ended September 26, 2020
Total net revenues
$662,917 $311,218 $142,004 $1,116,139 $— $1,116,139 
Intersegment net revenues
(227)(245)(2,801)(3,273)— (3,273)
Net revenues from external customers
$662,690 $310,973 $139,203 $1,112,866 $— $1,112,866 
Impairment and restructuring charges
$1,020 $506 $(174)$1,352 $(33)$1,319 
Adjusted EBITDA
$92,411 $39,970 $18,494 $150,875 $(20,125)$130,750 
Three Months Ended September 28, 2019
Total net revenues
$658,705 $287,703 $148,281 $1,094,689 $— $1,094,689 
Intersegment net revenues
(268)(13)(2,455)(2,736)— (2,736)
Net revenues from external customers
$658,437 $287,690 $145,826 $1,091,953 $— $1,091,953 
Impairment and restructuring charges
$1,133 $2,258 $4,513 $7,904 $31 $7,935 
Adjusted EBITDA
$66,671 $30,184 $20,343 $117,198 $(8,250)$108,948 
(amounts in thousands)North
America 		EuropeAustralasiaTotal Operating
Segments		Corporate
and
Unallocated
Costs		Total
Consolidated
Nine Months Ended September 26, 2020
Total net revenues
$1,858,310 $855,198 $379,693 $3,093,201 $— $3,093,201 
Intersegment net revenues
(771)(1,208)(6,823)(8,802)— (8,802)
Net revenues from external customers
$1,857,539 $853,990 $372,870 $3,084,399 $— $3,084,399 
Impairment and restructuring charges
$3,229 $2,660 $923 $6,812 $3,318 $10,130 
Adjusted EBITDA
$232,516 $91,650 $42,454 $366,620 $(35,644)$330,976 
Nine Months Ended September 28, 2019
Total net revenues
$1,893,273 $888,174 $447,004 $3,228,451 $— $3,228,451 
Intersegment net revenues
(1,358)(133)(5,760)(7,251)— (7,251)
Net revenues from external customers
$1,891,915 $888,041 $441,244 $3,221,200 $— $3,221,200 
Impairment and restructuring charges
$5,281 $4,210 $6,932 $16,423 $965 $17,388 
Adjusted EBITDA
$206,985 $86,810 $57,981 $351,776 $(25,968)$325,808 
Reconciliation of Net Income to Adjusted EBITDA
Reconciliations of net income to Adjusted EBITDA are as follows:
Three Months EndedNine Months Ended
(amounts in thousands)September 26, 2020September 28, 2019September 26, 2020September 28, 2019
Net income$25,480 $17,042 $48,347 $55,175 
Income tax expense 15,969 22,500 27,569 45,030 
Depreciation and amortization33,538 34,921 99,755 99,749 
Interest expense, net18,784 17,571 54,464 53,719 
Impairment and restructuring charges(1)
1,355 8,217 10,393 18,534 
(Gain) loss on sale of property and equipment(287)1 (2,697)1,081 
Share-based compensation expense2,767 4,108 11,662 10,585 
Non-cash foreign exchange transaction/translation (income) loss
2,963 (182)10,558 3,615 
Other items (2)
30,181 4,770 70,755 37,586 
Costs relating to debt restructuring and debt refinancing
— — 170 — 
Other non-cash items (3)
— — — 734 
Adjusted EBITDA$130,750 $108,948 $330,976 $325,808 
(1)Impairment and restructuring charges consist of (i) impairment and restructuring charges that are included in our consolidated unaudited statements of operations plus (ii) additional charges relating to inventory and/or manufacturing of our products that are included in cost of sales in the accompanying unaudited consolidated statements of operations in the amount of $36 and $282 for the three months ended September 26, 2020 and September 28, 2019, respectively, and $263 and $1,146 for the nine months ended September 26, 2020 and September 28, 2019, respectively. For further explanation of impairment and restructuring charges that are included in our consolidated statements of operations, see Note 17 - Impairment and Restructuring Charges in our financial statements.
(2)Other non-recurring items not core to ongoing business activity include: (i) in the three months ended September 26, 2020 (1) $27,760 in legal costs and professional expenses relating primarily to litigation, (2) $1,289 in facility closure, consolidation, and startup costs, and (3) $1,142 of realized losses on hedges of intercompany notes; (ii) in the three months ended September 28, 2019 (1) $3,599 in legal costs and professional expenses relating primarily to litigation, (2) ($3,021) of realized gains on hedges of intercompany notes, (3) $2,557 in facility closure, consolidation, and startup costs, and (4) $1,435 in acquisition and integration costs; (iii) in the nine months ended September 26, 2020 (1) $62,460 in legal costs and professional expenses relating primarily to litigation, (2) $5,366 in facility closure, consolidation, and startup costs, (3) $1,235 in one-time lease termination charges, and (4) $1,142 of realized losses on hedges of intercompany notes; (iv) in the nine months ended September 28, 2019 (1) $15,708 in facility closure, consolidation, and startup costs, (2) $13,432 in acquisition and integration costs including $7,077 related to purchase price structured by the former owners as retention payments for key employees of a recent acquisition, (3) $9,887 in legal costs and professional expenses relating primarily to litigation, (4) ($3,053) of realized gains on hedges of intercompany notes, (5) $987 in miscellaneous costs, and (6) $625 in costs related to departure of former executives.
(3)Other non-cash items include $734 in the nine months ended September 28, 2019 for inventory adjustments.
The prior period information has been reclassified to conform with current period presentation.